Please ensure Javascript is enabled for purposes of website accessibility

Teva Pharmaceutical to acquire Sicor for $3.4 billion

Teva Pharmaceutical to acquire Sicor for $3.4 billion

Listen to this article

Teva Pharmaceutical Industries Ltd. said Friday it will acquire Sicor Inc. for $3.4 billion in cash and stock, aiming to expand its reach in injectable generic drugs, Reuters reported. Teva is an Israeli company that makes generic drugs and the multiple sclerosis medicine Copaxone.

<